Nasal spray may stop dementia

Researchers at Osaka City University in Japan found that a nasal spray containing a combination of the antibiotic rifampicin and the natural compound resveratrol significantly improved the cognitive function of mice with Alzheimer’s disease, frontotemporal dementia, and Parkinson’s dementia (dementia with Lewy bodies). Dementia is thought to occur when proteins called amyloid-beta, tau, and alpha-synuclein cluster together and form sticky oligomers that accumulate in the brain and impair cognitive function. The combination of intranasal rifampicin and resveratrol inhibited the accumulation of these oligomers and restored synaptophysin levels—a presynaptic protein that facilitates normal synaptic function.

Comments: To take this further, in addition to intranasal rifampicin and resveratrol, I recommend considering oral lithium and fisetin and intravenous ozone to target the numerous mechanisms that lead to “cognitive frailty,” as well as injectable glycyl-L-histidyl-L-lysine to promote favorable gene expression relevant to the health and function of the central nervous system, and intranasal oxytocin to help restore hippocampal synaptic plasticity.

For more information:

Lazzara CA, Kim YH. Potential application of lithium in Parkinson’s and other neurodegenerative diseases. Front Neurosci. 2015;9:403.

Maher P. How fisetin reduces the impact of age and disease on CNS function. Front Biosci (Schol Ed). 2015;7:58-82.

Pickart L, Vasquez-Soltero JM, Margolina A. The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline. Brain Sci. 2017;7(2):20.

Scassellati C, Ciani M, Galoforo AC, Zanardini R, Bonvicini C, Geroldi C. Molecular mechanisms in cognitive frailty: potential therapeutic targets for oxygen-ozone treatment. Mech Ageing Dev. 2020 Mar;186:111210.

Takahashi J, Yamada D, Ueta Y, Iwai T, Koga E, Tanabe M, Oka JI, Saitoh A. Oxytocin reverses Aβ-induced impairment of hippocampal synaptic plasticity in mice. Biochem Biophys Res Commun. 2020 Jul 12;528(1):174-178.

Umeda T, Sakai A, Shigemori K, Yokota A, Kumagai T, Tomiyama T. Oligomer-Targeting Prevention of Neurodegenerative Dementia by Intranasal Rifampicin and Resveratrol Combination – A Preclinical Study in Model Mice. Front Neurosci. 2021;15:763476.